Abstract
A 50-year-old man with ankylosing spondylitis who developed neutropenia after treatment of etanercept, with two positive rechallenges, and after the first infliximab infusion, is described. Although leukopenia and neutropenia related to etanercept and infliximab have been described as rare adverse events from clinical trials data, their mechanism of action are unknown. This patient developed recurrent mild neutropenia after exposition of two different antitumor necrosis factors; therefore, it seems to be an adverse reaction related to the therapeutic group. Doctors should be aware of this potentially severe adverse effect in patients treated with antitumor necrosis factor.
References
Khanna D, McMahon M, Furst DE (2004) Safety of tumor necrosis factor-α antagonists. Drug Saf 27:307–324
Day R (2002) Adverse reactions of TNF-α inhibitors in rheumatoid arthritis. Lancet 359:540–541
Hyrich KL, Silman AJ, Watson KD, Symmons DPM (2004) Anti-tumor necrosis factor α therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 63:1538–1543
Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A (2002) Safety and efficacy of disease-modifying anti-rheumatic agents. Drug Saf 25:173–197
Malgarini RB, Pimpinella G (2004) Etanercept and methotrexate in rheumatoid arthritis. Lancet 363:1733
Feltelius N, Fored CM, Blomqvist P, Bertilsson L, Geborek P, Jacobsson LT et al (2005) Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept. Ann Rheum Dis 64:246–252
Berliner N, Horwitz M, Loughran TP (2004) Congenital and acquired neutropenia. Hematology (Am Soc Hematol Educ Program) 2004:63–79
Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Lundin FE Jr (1993) Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med 153:2119–2124
Vidal F, Fontova R, Richart C (2003) Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 139:W–W63
Ghavami A, Genevay S, Fulpius T, Gabay C (2005) Etanercept in treatment of Felty’s syndrome. Ann Rheum Dis 64:1090–1091
Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R et al (2004) Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum 50:1412–1419
Phelan C, Wooltorton E (2004) Infliximab and serious hematologic events. Can Med Assoc J 171:1045
Menon Y, Cucurull E, Espinoza LR (2003) Pancytopenia in a patient with scleroderma treated with infliximab. Rheumatology 42:1273–1274
Favalli EG, Varenna M, Sinigaglia L (2005) Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy. Clin Exp Rheumatol 23:247–250
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Montané, E., Sallés, M., Barriocanal, A. et al. Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges. Clin Rheumatol 26, 1527–1529 (2007). https://doi.org/10.1007/s10067-006-0415-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0415-y